6/18/2013

Results from PET scans were mixed for an experimental vaccine aimed at lowering the amount of nicotine that reaches the brains of smokers, according to findings presented at the SNMMI Annual Meeting. "Ideally, we want [the vaccine] to decrease amount of nicotine that reaches the brain, but when we compared the immune response across subjects, their antibodies appeared to vary in nicotine-binding properties," said Dr. Alexey Mukhin of Duke University.

Full Story:
Diagnostic Imaging

Related Summaries